pubmed-article:16230137 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16230137 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16230137 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
pubmed-article:16230137 | lifeskim:mentions | umls-concept:C1704272 | lld:lifeskim |
pubmed-article:16230137 | lifeskim:mentions | umls-concept:C0426733 | lld:lifeskim |
pubmed-article:16230137 | lifeskim:mentions | umls-concept:C0006050 | lld:lifeskim |
pubmed-article:16230137 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
pubmed-article:16230137 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16230137 | pubmed:dateCreated | 2005-10-18 | lld:pubmed |
pubmed-article:16230137 | pubmed:abstractText | To expand the clinical use of botulinum toxin A (BTX-A) in treating patients with small prostates and symptomatic benign prostatic hyperplasia (BPH). BTX-A injection into the prostate in patients with voiding dysfunction and large prostates has been reported. | lld:pubmed |
pubmed-article:16230137 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16230137 | pubmed:language | eng | lld:pubmed |
pubmed-article:16230137 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16230137 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16230137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16230137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16230137 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16230137 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16230137 | pubmed:issn | 1527-9995 | lld:pubmed |
pubmed-article:16230137 | pubmed:author | pubmed-author:YoshimuraNaok... | lld:pubmed |
pubmed-article:16230137 | pubmed:author | pubmed-author:ChancellorMic... | lld:pubmed |
pubmed-article:16230137 | pubmed:author | pubmed-author:HuangChao-Che... | lld:pubmed |
pubmed-article:16230137 | pubmed:author | pubmed-author:ChuangYao-Chi... | lld:pubmed |
pubmed-article:16230137 | pubmed:author | pubmed-author:ChiangPo-HuiP... | lld:pubmed |
pubmed-article:16230137 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16230137 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:16230137 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16230137 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16230137 | pubmed:pagination | 775-9 | lld:pubmed |
pubmed-article:16230137 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:16230137 | pubmed:meshHeading | pubmed-meshheading:16230137... | lld:pubmed |
pubmed-article:16230137 | pubmed:meshHeading | pubmed-meshheading:16230137... | lld:pubmed |
pubmed-article:16230137 | pubmed:meshHeading | pubmed-meshheading:16230137... | lld:pubmed |
pubmed-article:16230137 | pubmed:meshHeading | pubmed-meshheading:16230137... | lld:pubmed |
pubmed-article:16230137 | pubmed:meshHeading | pubmed-meshheading:16230137... | lld:pubmed |
pubmed-article:16230137 | pubmed:meshHeading | pubmed-meshheading:16230137... | lld:pubmed |
pubmed-article:16230137 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16230137 | pubmed:articleTitle | Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. | lld:pubmed |
pubmed-article:16230137 | pubmed:affiliation | Division of Urology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan. | lld:pubmed |
pubmed-article:16230137 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16230137 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16230137 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16230137 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16230137 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16230137 | lld:pubmed |